Vildagliptin plus metformin combination therapy provides superior glycaemic control to individual monotherapy in treatment‐naive patients with type 2 diabetes mellitus
Year: 2009
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Diabetes Obesity and Metabolism
Institutions: Vita-Salute San Raffaele University, University of Siena
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: vildagliptin, metformin, combination therapy, type 2 diabetes, treatment-naive patients, glycemic control, HbA1c, DPP-4 inhibitors, initial treatment, monotherapy comparison, treatment failure, tolerability, hypoglycemia, gastrointestinal adverse effects, renal safety, liver function tests
Open Access status: closed
OpenAlex ID: W2137471483
